Post by Andy Peacher Tel 07827731060 on Mar 20, 2012 9:32:01 GMT
Professor Gordon Stewart.
Prof Gordon Stewart has been speaking out on the Adverse Reactions to Vaccines since 1950's.
His main work is surrounding the Whooping Cough and DPT vaccine. Over the years he has written
letter after letter raising concerns to the Department of Health and the Government.
Most of his concerns were ignored but they were discussed at meetings involving
the Joint Sub Committee on Adverse Reactions to Vaccination and Immunisation.
Professor Gordon Stewart's views make him unconventional among medical men but his opinions and advice are of great importance to the parents of children who are candidates for whooping cough vaccine. Vaccination to Professor Stewart spells one word:
DANGER
Here is a list of his papers
GORDON T STEWART
GORDON T. STEWART, M.D Emeritus professor of Public Health, University of Glasgow
Consultant physician, NHS (Epidemiology and Preventive Medicine), Emeritus Fellow, Inf Dis Soc of
America. Former consultant, New York City, US NIH, WHO, UNICEF etc.
MAIN PUBLICATIONS RELATING TO VACCINATIONS.
1951 Infectivity and virulence of tubercle bacilli. Lancet 2; 562
1952 do J Hygiene, Cambridge 50; 37.
1962 Organisation of Clinical Trials Lancet 1, 1394
1968 Limitations of the germ theory Lancet 1; 1077
1969 Determinants of sickness in US Marine recruits Amer J Epid 89;254
1969 Resistance factors in the control of tuberculosis J Inf Dis 120; 389
1976 Immunisation against whooping cough Brit med J 1; 93.
1976 Immunisation against whooping cough ibid 1; 583
1976 (with WR Bassili) Whooping cough: epidemiological evaluation of immunisation and other factors in the control of infection. Lancet 1; 474.
1977 Vaccination against whooping cough: efficacy versus risks. Lancet 1; 234.
1977 Whooping cough vaccination. Lancet 1; 804
1978 Whooping cough vaccination Brit med J 2; 768
Pertussis vaccine: the United Kingdom's experience: Invited position paper at the NIH Symposium on Pertussis at Bethesda, Md.,1978. US Government Printing Office: 1979.
1979 Toxicity of pertussis vaccine. frequency and probability of adverse reactions. J Epid Comm Health 33; 150
1979 Infection and immunisation Scot med J 24; 47
1979 Deaths of infants after triple vaccine Lancet 2; 353
1979 Whooping cough in Hertfordshire, UK Lancet 2; 473
1979 Whooping cough in Shetland, UK Brit med J;
1980 Vaccination and notification rates for whooping cough Lancet 1; 1299
1980 Pertussis vaccine: benefits and risks. New Eng J Med 302; 634.
1981 Whooping cough in relation to other childhood infections. J Epid Comm Hlth 35; 139
Pertussis vaccine and acute neurological illness in children Brit med J 282, 1968
(with John Wilson)
Medicine and the Community. Chapter 3 in "Legal Issues in Medicine" ed MacLean, SMM, Gower Pub Co., Aldershot, UK.
1982 ABC of whooping cough Brit med J. 284; 1263
1983 Whooping cough in the United States and Britain New Eng J Med 308; 464
1983 Whooping cough and pertussis vaccine Brit med J 287; 287
1983 Whooping cough and pertussis vaccine: Report commissioned by the Chief Scientist, Dept of Health and Social Security (UK) on Risk-benefit of pertussis vaccines in UK, 1964-82 (pp 135).
Whooping cough and pertussis vaccine: Risks and benefit debate. Amer J Epid 119; 135
1982 Age-specific immunisation schedules. Lancet I ; 806.
Pertussis vaccine: is the policy right? World Medicine 19; 17
1984 Admission of children to hospitals in Glasgow; relation to unemployment and other
deprivation variables including vaccinations. ```````````Lancet 2; 682
1984 Whooping cough and pertussis vaccine: a comparison of the risks and benefits in Britain from 1968 -83 (Invited contribution to the WHO/IBAS Symposium on pertussis, Geneva: (see Developments in Biological Standards 1985; 61; 395: Karger, Basel), .
1986 Viruses in acute childhood encephalopathy Lancet 3, 405.
1990 Safety of pertussis vaccine Lancet 335; 1162.
1995 Public Health: Whither or Whether? Soc of Public Health, Year Book (By invitation), 3.
1996 Review: Enforced vaccination against hepatitis B. Bull Med Ethics No 115, 15.
1997 Invited Comment to the Lord Chancellor (UK) on Access to Justice (Medical aspects).
1999 Ethics and Risk-benefit in Vaccination. By invitation to EURO Conference 12-14 June 1997 in Rome, Italy. Archives of Clinical Bioethics, 1999; II (1); 56-60 (English version).
1999 Immunisation with gp 160 in HIV-1 infection. (with C Fiala) Lancet 354; 948.
Prof Gordon Stewart has been speaking out on the Adverse Reactions to Vaccines since 1950's.
His main work is surrounding the Whooping Cough and DPT vaccine. Over the years he has written
letter after letter raising concerns to the Department of Health and the Government.
Most of his concerns were ignored but they were discussed at meetings involving
the Joint Sub Committee on Adverse Reactions to Vaccination and Immunisation.
Professor Gordon Stewart's views make him unconventional among medical men but his opinions and advice are of great importance to the parents of children who are candidates for whooping cough vaccine. Vaccination to Professor Stewart spells one word:
DANGER
Here is a list of his papers
GORDON T STEWART
GORDON T. STEWART, M.D Emeritus professor of Public Health, University of Glasgow
Consultant physician, NHS (Epidemiology and Preventive Medicine), Emeritus Fellow, Inf Dis Soc of
America. Former consultant, New York City, US NIH, WHO, UNICEF etc.
MAIN PUBLICATIONS RELATING TO VACCINATIONS.
1951 Infectivity and virulence of tubercle bacilli. Lancet 2; 562
1952 do J Hygiene, Cambridge 50; 37.
1962 Organisation of Clinical Trials Lancet 1, 1394
1968 Limitations of the germ theory Lancet 1; 1077
1969 Determinants of sickness in US Marine recruits Amer J Epid 89;254
1969 Resistance factors in the control of tuberculosis J Inf Dis 120; 389
1976 Immunisation against whooping cough Brit med J 1; 93.
1976 Immunisation against whooping cough ibid 1; 583
1976 (with WR Bassili) Whooping cough: epidemiological evaluation of immunisation and other factors in the control of infection. Lancet 1; 474.
1977 Vaccination against whooping cough: efficacy versus risks. Lancet 1; 234.
1977 Whooping cough vaccination. Lancet 1; 804
1978 Whooping cough vaccination Brit med J 2; 768
Pertussis vaccine: the United Kingdom's experience: Invited position paper at the NIH Symposium on Pertussis at Bethesda, Md.,1978. US Government Printing Office: 1979.
1979 Toxicity of pertussis vaccine. frequency and probability of adverse reactions. J Epid Comm Health 33; 150
1979 Infection and immunisation Scot med J 24; 47
1979 Deaths of infants after triple vaccine Lancet 2; 353
1979 Whooping cough in Hertfordshire, UK Lancet 2; 473
1979 Whooping cough in Shetland, UK Brit med J;
1980 Vaccination and notification rates for whooping cough Lancet 1; 1299
1980 Pertussis vaccine: benefits and risks. New Eng J Med 302; 634.
1981 Whooping cough in relation to other childhood infections. J Epid Comm Hlth 35; 139
Pertussis vaccine and acute neurological illness in children Brit med J 282, 1968
(with John Wilson)
Medicine and the Community. Chapter 3 in "Legal Issues in Medicine" ed MacLean, SMM, Gower Pub Co., Aldershot, UK.
1982 ABC of whooping cough Brit med J. 284; 1263
1983 Whooping cough in the United States and Britain New Eng J Med 308; 464
1983 Whooping cough and pertussis vaccine Brit med J 287; 287
1983 Whooping cough and pertussis vaccine: Report commissioned by the Chief Scientist, Dept of Health and Social Security (UK) on Risk-benefit of pertussis vaccines in UK, 1964-82 (pp 135).
Whooping cough and pertussis vaccine: Risks and benefit debate. Amer J Epid 119; 135
1982 Age-specific immunisation schedules. Lancet I ; 806.
Pertussis vaccine: is the policy right? World Medicine 19; 17
1984 Admission of children to hospitals in Glasgow; relation to unemployment and other
deprivation variables including vaccinations. ```````````Lancet 2; 682
1984 Whooping cough and pertussis vaccine: a comparison of the risks and benefits in Britain from 1968 -83 (Invited contribution to the WHO/IBAS Symposium on pertussis, Geneva: (see Developments in Biological Standards 1985; 61; 395: Karger, Basel), .
1986 Viruses in acute childhood encephalopathy Lancet 3, 405.
1990 Safety of pertussis vaccine Lancet 335; 1162.
1995 Public Health: Whither or Whether? Soc of Public Health, Year Book (By invitation), 3.
1996 Review: Enforced vaccination against hepatitis B. Bull Med Ethics No 115, 15.
1997 Invited Comment to the Lord Chancellor (UK) on Access to Justice (Medical aspects).
1999 Ethics and Risk-benefit in Vaccination. By invitation to EURO Conference 12-14 June 1997 in Rome, Italy. Archives of Clinical Bioethics, 1999; II (1); 56-60 (English version).
1999 Immunisation with gp 160 in HIV-1 infection. (with C Fiala) Lancet 354; 948.